Jun 02, 2019 / 11:00PM GMT
Richard A. Miller - Corvus Pharmaceuticals, Inc. - Co-Founder, President, CEO & Chairman of the Board
All right. I think you can unmute me now. Ready to go? Great. First of all, thank you very much, all of you, for attending. This is a great turnout on a Sunday night. At least I think it's Sunday. I'm not sure what day it is. I've lost track, but we appreciate you all coming. We have, I think, a very interesting agenda for you tonight.
As you know, we presented, I think, a really beautiful paper this morning, presented by Dr. Luke, who's joining us this evening. Dr. Luke, of course, did this work while at the University of Chicago, but he's recently moved to the University of Pittsburgh. So if you're a Steelers' fan, you'll be happy.
The paper today that Dr. Luke presented makes me extremely proud of the work of our collaborators and the work of people at our company. For those of you who were there, it is -- and I have been doing this for like 30 years, it was a great, great demonstration of a really nicely conducted Phase I study that had beautiful safety, early assessments of
Corvus Pharmaceuticals Inc ASCO Investor and Analyst Reception Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot